Ed Arce
Stock Analyst at Westpark Capital
(4.86)
# 372
Out of 5,043 analysts
1034
Total ratings
48.8%
Success rate
23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ed Arce
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERU Veru Inc. | Initiated Coverage: Buy | $28 | $2.42 | +1,057.02% | 1 | Oct 6, 2026 | |
| AKBA Akebia Therapeutics | Initiated Coverage: Buy | $7.5 → $4.5 | $0.8148 | +452.28% | 86 | Sep 8, 2026 | |
| TLPH Talphera | Initiated Coverage: Buy | $6 → $3 | $1.08 | +177.78% | 88 | Apr 30, 2026 | |
| MTVA MetaVia | Reiterated: Buy | $132 | $1.34 | n/a | 9 | Sep 17, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $60 | $12.87 | n/a | 72 | Apr 11, 2025 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $75 | $4.07 | n/a | 33 | Apr 11, 2025 | |
| IVA Inventiva | Reiterated: Buy | $13 | $3.32 | n/a | 32 | Apr 3, 2025 | |
| GALT Galectin Therapeutics | Reiterated: Hold | n/a | $3.64 | n/a | 56 | Apr 2, 2025 | |
| ALGS Aligos Therapeutics | Reiterated: Buy | $70 | $5.31 | n/a | 6 | Mar 31, 2025 | |
| ASMB Assembly Biosciences | Reiterated: Hold | n/a | $22.82 | n/a | 30 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 | $1.25 | n/a | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.00 | n/a | 36 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $8.92 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $405 | $476.91 | n/a | 42 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $72 | $81.35 | n/a | 60 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5.5 | $3.27 | n/a | 13 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $15.29 | n/a | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $12.10 | n/a | 16 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.18 | n/a | 37 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $21.26 | n/a | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $22 | $52.04 | n/a | 26 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.000001 | n/a | 44 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $16.22 | n/a | 90 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.10 | n/a | 12 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $0.07975 | n/a | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $29.73 | n/a | 12 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 51 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.17 | n/a | 13 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.4298 | n/a | 33 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.33 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €2.80 | n/a | 15 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $31 | $22.11 | n/a | 11 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1772 | n/a | 5 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $1.14 | n/a | 5 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.25 | $0.012 | n/a | 14 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $27.73 | n/a | 2 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.43448 | n/a | 8 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.000001 | n/a | 1 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.29 | n/a | 12 | Jan 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $5 | $0.000101 | n/a | 8 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.5 | $0.0016 | n/a | 2 | Mar 19, 2013 |
Veru Inc.
Oct 6, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $2.42
Upside: +1,057.02%
Akebia Therapeutics
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $7.5 → $4.5
Current: $0.8148
Upside: +452.28%
Talphera
Apr 30, 2026
Initiated Coverage: Buy
Price Target: $6 → $3
Current: $1.08
Upside: +177.78%
MetaVia
Sep 17, 2025
Reiterated: Buy
Price Target: $132
Current: $1.34
Upside: n/a
Arcturus Therapeutics Holdings
Apr 11, 2025
Reiterated: Buy
Price Target: $60
Current: $12.87
Upside: n/a
Unicycive Therapeutics
Apr 11, 2025
Reiterated: Buy
Price Target: $75
Current: $4.07
Upside: n/a
Inventiva
Apr 3, 2025
Reiterated: Buy
Price Target: $13
Current: $3.32
Upside: n/a
Galectin Therapeutics
Apr 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.64
Upside: n/a
Aligos Therapeutics
Mar 31, 2025
Reiterated: Buy
Price Target: $70
Current: $5.31
Upside: n/a
Assembly Biosciences
Mar 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $22.82
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $240
Current: $1.25
Upside: n/a
Mar 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.00
Upside: n/a
Mar 11, 2025
Reiterated: Buy
Price Target: $32
Current: $8.92
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $400 → $405
Current: $476.91
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $66 → $72
Current: $81.35
Upside: n/a
Feb 20, 2025
Reiterated: Hold
Price Target: $5.5
Current: $3.27
Upside: n/a
Feb 18, 2025
Reiterated: Buy
Price Target: $95
Current: $15.29
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $18
Current: $12.10
Upside: n/a
Jan 21, 2025
Reiterated: Buy
Price Target: $5
Current: $4.18
Upside: n/a
Jan 14, 2025
Reiterated: Buy
Price Target: $48
Current: $21.26
Upside: n/a
Jan 14, 2025
Reiterated: Buy
Price Target: $18 → $22
Current: $52.04
Upside: n/a
Sep 10, 2024
Reiterated: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Sep 5, 2024
Reiterated: Buy
Price Target: $13
Current: $16.22
Upside: n/a
Apr 24, 2024
Rated: Hold
Price Target: n/a
Current: $1.10
Upside: n/a
Mar 26, 2024
Reiterated: Buy
Price Target: $120
Current: $0.07975
Upside: n/a
Jan 25, 2024
Reiterated: Buy
Price Target: $25
Current: $29.73
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 21, 2021
Reiterated: Hold
Price Target: n/a
Current: $17.17
Upside: n/a
Nov 29, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.4298
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $8.33
Upside: n/a
Mar 18, 2020
Reiterated: Buy
Price Target: €12.00
Current: €2.80
Upside: n/a
Feb 7, 2020
Reiterated: Buy
Price Target: $29 → $31
Current: $22.11
Upside: n/a
Nov 11, 2019
Reiterated: Hold
Price Target: n/a
Current: $0.1772
Upside: n/a
Aug 12, 2019
Reiterated: Buy
Price Target: $27
Current: $1.14
Upside: n/a
Mar 14, 2019
Reiterated: Hold
Price Target: $1.25
Current: $0.012
Upside: n/a
Nov 28, 2017
Rated: Buy
Price Target: $7
Current: $27.73
Upside: n/a
Nov 6, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.43448
Upside: n/a
Jan 30, 2015
Reiterated: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Jan 26, 2015
Reiterated: Buy
Price Target: $20
Current: $8.29
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $7.5 → $5
Current: $0.000101
Upside: n/a
Mar 19, 2013
Downgraded: Sell
Price Target: $0.5
Current: $0.0016
Upside: n/a